It’s Time to Deepen the Gene Pool
By Daniel R. Matlis In my “Final Word” column, published in Pharmaceutical Formulation and Quality, I discussed the need to deepen our industry’s gene pool. […]
It’s Time to Deepen the Gene Pool Read More »
Life Sciences Industry is an Emerging Powerhouse in Pennsylvania
By Daniel R. Matlis According to a recent study by the Milken Institute the life sciences industry is an emerging powerhouse for U.S. global
Life Sciences Industry is an Emerging Powerhouse in Pennsylvania Read More »
FDA Issues Final cGMP Guidance
By Daniel R. Matlis Yesterday, on the heels of the release of a critical Institute of Medicine Report, the FDA issued a Final Guidance
FDA Issues Final cGMP Guidance Read More »
FDA Drug Safety System Needs Fixing, IOM Report Says
By Daniel R. Matlis According to a report issued by the Institute of Medicine (IOM), the FDA suffers from a lack of clear regulatory authority,
FDA Drug Safety System Needs Fixing, IOM Report Says Read More »
ImClone Loses Patent Decision for Cancer Drug Erbitux
By Leslie Gladstone Restaino, Esq. ImClone Systems, Inc. is reeling from a court decision Monday invalidating ownership of a significant patent for the company’s cancer
ImClone Loses Patent Decision for Cancer Drug Erbitux Read More »
Compounding Redux
By Daniel R. Matlis Recently, I wrote an article calling for consistent federal regulatory requirements for the practice of compounding. Last month, the US District
FDA Approves First Implantable Replacement Heart
The U.S. Food and Drug Administration (FDA) yesterday approved the AbioCor®, the world’s first completely self-contained, implantable Replacement Heart. This approval provides patients suffering from
FDA Approves First Implantable Replacement Heart Read More »
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia?
By Daniel R. Matlis It’s a trick question. Technically both should be sterile. But you would think that cardioplegia, the solution used to stop the
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia? Read More »
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia?
By Daniel R. Matlis It’s a trick question. Technically both should be sterile. But you would think that cardioplegia, the solution used to stop the
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia? Read More »
The impact of IBM’s Acquisition of MRO Software on the Life-Sciences Market
On August 3, 2006 MRO Software announced that it has agreed to be acquired by IBM. So, what the impact on Life-Sciences Customers? I think
The impact of IBM’s Acquisition of MRO Software on the Life-Sciences Market Read More »
Can I make your pacemaker software run faster?
I recently read an article on the Free Software Foundation’s Website entitled “Regulatory compliance is no reason to lock up users” The author states that
Can I make your pacemaker software run faster? Read More »
Doctors Don’t Treat Populations, They Treat Individual Patients
This week, Scott Gottlieb, MD Deputy Commissioner for Medical and Scientific Affairs at the Food and Drug Administration made an interesting speech before the 2006
Doctors Don’t Treat Populations, They Treat Individual Patients Read More »